See full blog here: https://ndriresource.org/htorr-program-joins-rrdi-initiative-for-citing-biological-resources/
The National Disease Research Interchange (NDRI) has announced that its Human Tissues and Organs for Research Resource (HTORR) program is participating in the Research Resource Identification (#RRID) Initiative. This initiative is designed to help researchers cite the key biological resources used to produce their scientific findings.
The #RRID Initiative aims to enable resource transparency within biomedical literature by promoting the use of unique Research Resource Identifiers (RRIDs). RRIDs are Persistent Unique Identifiers, meaning each number refers to only one specific specimen, and it will never be changed or reused. RRIDs facilitate rigor and reproducibility, as well as continuity tracking, by allowing scientists to unambiguously cite and link to millions of Key Biological Resources on the RRID portal.
NDRI’s HTORR program has been continuously funded by the National Institutes of Health (NIH) for almost 35 consecutive years to support NIH-funded and academic research programs across multiple disciplines. The HTORR Program provides biomedical investigators with donated normal and diseased human tissues and organs recovered using project-specific procurement, processing, preservation, and distribution protocols. HTORR also provides tissue-type and disease-type histopathological verification of samples.
“We are excited to bring the HTORR program into alignment with the RRID Initiative,” said Thomas Bell, MS, PhD, Chief Scientific Officer of NDRI. “RRID is a comprehensive, intelligent solution to the need for transparent, rigorous, and reproducible research.”
NDRI has long recognized the value of RRIDs and previously attached RRIDs to both NDRI (RRID:SCR_000550) and HTORR (RRID:SCR_002859) as research tools. Now, NDRI is working to expand the incorporation of this important initiative by cataloging the specimens in its extensive Ocular Slide Program. This program offers specimens from donors with various ocular diseases, such as Macular Degeneration or Glaucoma from NDRI’s College of American Pathologists (CAP) accredited on-site biorepository.